Literature DB >> 11523227

Y specific sequence gene analysis of single fetal nucleated erythroblasts from the peripheral blood of pregnant women.

T Wang1, H Chen, Y Lu, T Ma.   

Abstract

The single cell isolation technique was used to detect fetal nucleated erythroblasts (FNRBCs) at a single cell level from the peripheral blood of pregnant women in order to investigate the feasibility of this method for noninvasive prenatal diagnosis. Single fetal nucleated erythroblasts were isolated from the peripheral blood samples from 51 pregnant women (14 to 26 weeks of gestation) by micromanipulation techniques after density gradient centrifugation. Nested polymerase chain reaction method was used to amplify the SRY gene. It was found that the concordance rate of amplification results with real fetal sex was 82.61%. The sensitivity and specificity were 80% and 87.50% respectively. It was suggested that it is feasible and promising in non invasive prenatal diagnosis to detect fetal nucleated erythroblasts at a single cell level by using micromanipulation techniques.

Entities:  

Mesh:

Year:  2001        PMID: 11523227     DOI: 10.1007/BF02888086

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  9 in total

1.  Prenatal diagnosis of beta-thalassaemia using fetal erythroblasts enriched from maternal blood by a novel gradient.

Authors:  E Di Naro; F Ghezzi; A Vitucci; N Tannoia; D Campanale; V D'Addario; W Holzgreve; S Hahn
Journal:  Mol Hum Reprod       Date:  2000-06       Impact factor: 4.025

Review 2.  Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review.

Authors:  C D Steele; R J Wapner; J B Smith; M K Haynes; L G Jackson
Journal:  Clin Obstet Gynecol       Date:  1996-12       Impact factor: 2.190

3.  Erythroid-specific antibodies enhance detection of fetal nucleated erythrocytes in maternal blood.

Authors:  D W Bianchi; G K Zickwolf; M C Yih; A F Flint; O H Geifman; M S Erikson; J M Williams
Journal:  Prenat Diagn       Date:  1993-04       Impact factor: 3.050

4.  Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis: experiences with triple density gradient and MACS based on more than 600 cases.

Authors:  D Gänshirt; F W Smeets; A Dohr; C Walde; I Steen; C Lapucci; C Falcinelli; R Sant; M Velasco; H S Garritsen; W Holzgreve
Journal:  Fetal Diagn Ther       Date:  1998 Sep-Oct       Impact factor: 2.587

5.  Frequencies of fetal nucleated red blood cells in maternal blood during different stages of gestation.

Authors:  P L Kuo
Journal:  Fetal Diagn Ther       Date:  1998 Nov-Dec       Impact factor: 2.587

6.  Development of non-invasive fetal DNA diagnosis from maternal blood.

Authors:  H Takabayashi; S Kuwabara; T Ukita; K Ikawa; K Yamafuji; T Igarashi
Journal:  Prenat Diagn       Date:  1995-01       Impact factor: 3.050

7.  Fetal nucleated cells in maternal peripheral blood after delivery.

Authors:  H Hamada; T Arinami; H Hamaguchi; T Kubo
Journal:  Am J Obstet Gynecol       Date:  1994-04       Impact factor: 8.661

8.  Prenatal diagnosis of ornithine transcarbamylase deficiency by using a single nucleated erythrocyte from maternal blood.

Authors:  A Watanabe; A Sekizawa; A Taguchi; H Saito; T Yanaihara; M Shimazu; I Matsuda
Journal:  Hum Genet       Date:  1998-06       Impact factor: 4.132

9.  Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.

Authors:  D W Bianchi; G K Zickwolf; G J Weil; S Sylvester; M A DeMaria
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.